Asona Lui • UCSD Profiles (original) (raw)

  1. Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost. Int J Radiat Oncol Biol Phys. 2024 Nov 15; 120(4):1024-1031. Zhong AY, Lui AJ, Kuznetsova S, Kallis K, Conlin C, Do DD, Domingo MR, Manger R, Hua P, Karunamuni R, Kuperman J, Dale AM, Rakow-Penner R, Hahn ME, van der Heide UA, Ray X, Seibert TM. PMID: 38925224.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  2. Healthy lifestyle and prostate cancer risk in the Million Veteran Program. Cancer. 2024 Oct 15; 130(20):3496-3505. Pagadala MS, Lui A, Lynch J, Karunamuni R, Lee KM, Plym A, Rose BS, Carter H, Kibel AS, DuVall SL, Vassy J, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. PMID: 38865417.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  3. Agent orange exposure and prostate cancer risk in the million veteran program. Acta Oncol. 2024 May 23; 63:373-378. Pagadala MS, Lui AJ, Zhong AY, Lynch JA, Karunamuni R, Lee KM, Plym A, Rose BS, Carter HK, Kibel AS, DuVall SL, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. PMID: 38779869; PMCID: PMC11332552.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  4. The Evolving Landscape of B Cells in Cancer Metastasis. Cancer Res. 2023 12 01; 83(23):3835-3845. Ramos MJ, Lui AJ, Hollern DP. PMID: 37815800; PMCID: PMC10914383.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansCells
  5. Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation. Radiat Oncol. 2023 Nov 11; 18(1):188. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM. PMID: 37950310; PMCID: PMC10638743.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  6. ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging. Int J Radiat Oncol Biol Phys. 2023 12 01; 117(5):1145-1152. Lui AJ, Kallis K, Zhong AY, Hussain TS, Conlin C, Digma LA, Phan N, Mathews IT, Do DD, Domingo MR, Karunamuni R, Kuperman J, Dale AM, Shabaik A, Rakow-Penner R, Hahn ME, Seibert TM. PMID: 37453559; PMCID: PMC11088932.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  7. Agent Orange exposure and prostate cancer risk in the Million Veteran Program. medRxiv. 2023 Jun 16. Lui AJ, Pagadala MS, Zhong AY, Lynch J, Karunamuni R, Lee KM, Plym A, Rose BS, Carter H, Kibel AS, DuVall SL, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. PMID: 37398205; PMCID: PMC10312838.
    View in: PubMed Mentions:
  8. Use of focal radiotherapy boost for prostate cancer and perceived barriers toward its implementation: a survey. medRxiv. 2023 Jun 08. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM. PMID: 37333345; PMCID: PMC10274968.
    View in: PubMed Mentions:
  9. Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging. Eur Urol Open Sci. 2023 Jan; 47:20-28. Zhong AY, Digma LA, Hussain T, Feng CH, Conlin CC, Tye K, Lui AJ, Andreassen MMS, Rodríguez-Soto AE, Karunamuni R, Kuperman J, Kane CJ, Rakow-Penner R, Hahn ME, Dale AM, Seibert TM. PMID: 36601040; PMCID: PMC9806706.
    View in: PubMed Mentions: 13
  10. HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer. Cancer J. 2022 Sep-Oct 01; 28(5):339-345. Saddawi-Konefka R, Schokrpur S, Lui AJ, Gutkind JS. PMID: 36165721; PMCID: PMC9523502.
    View in: PubMed Mentions: 13 Fields:
    Translation:HumansCells
  11. Correcting B0 inhomogeneity-induced distortions in whole-body diffusion MRI of bone. Sci Rep. 2022 01 07; 12(1):265. Digma LA, Feng CH, Conlin CC, Rodríguez-Soto AE, Zhong AY, Hussain TS, Lui AJ, Batra K, Simon AB, Karunamuni R, Kuperman J, Rakow-Penner R, Hahn ME, Dale AM, Seibert TM. PMID: 34997164; PMCID: PMC8741963.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  12. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24. Prostate Cancer Prostatic Dis. 2022 02; 25(2):229-237. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Lui A, Martinez ME, Rose BS, Mahal B, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, UKGPCS Collaborators, Tangen CM, Goodman PJ, Thompson IM, Blot WJ, Zheng W, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Park JY, Lin HY, Taylor JA, Bensen JT, Mohler JL, Fontham ETH, Multigner L, Blanchet P, Brureau L, Romana M, Leach RJ, John EM, Fowke JH, Bush WS, Aldrich MC, Crawford DC, Cullen J, Petrovics G, Parent MÉ, Hu JJ, Sanderson M, PRACTICAL Consortium, Mills IG, Andreassen OA, Dale AM, Seibert TM. PMID: 34127801; PMCID: PMC8669040.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansCells
  13. Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression. Cancer Lett. 2021 08 28; 514:12-29. Provance OK, Geanes ES, Lui AJ, Roy A, Holloran SM, Gunewardena S, Hagan CR, Weir S, Lewis-Wambi J. PMID: 34022283; PMCID: PMC8221017.
    View in: PubMed Mentions: 16 Fields:
    Translation:HumansAnimalsCells
  14. A rare case of group A streptococcal toxic-shock syndrome in a postpartum adolescent leading to multi-organ failure. Clin Case Rep. 2020 May; 8(5):793-797. Cortez Granados S, Batsch J, Lui A, Hessman J, Gloyeske N, Panchal A. PMID: 32477519; PMCID: PMC7250980.
    View in: PubMed Mentions: 1
  15. Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis. Mol Cancer Res. 2019 05; 17(5):1180-1194. Escher TE, Lui AJ, Geanes ES, Walter KR, Tawfik O, Hagan CR, Lewis-Wambi J. PMID: 30655323; PMCID: PMC6497545.
    View in: PubMed Mentions: 18 Fields:
    Translation:HumansAnimalsCells
  16. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Lett. 2017 07 28; 399:29-43. Lui AJ, Geanes ES, Ogony J, Behbod F, Marquess J, Valdez K, Jewell W, Tawfik O, Lewis-Wambi J. PMID: 28411130; PMCID: PMC5530765.
    View in: PubMed Mentions: 39 Fields:
    Translation:HumansAnimalsCells
  17. Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells. BMC Cancer. 2016 07 16; 16:487. Lui A, New J, Ogony J, Thomas S, Lewis-Wambi J. PMID: 27421652; PMCID: PMC4947349.
    View in: PubMed Mentions: 36 Fields:
    Translation:HumansCells
  18. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner. Breast Cancer Res. 2016 Feb 20; 18(1):25. Ogony J, Choi HJ, Lui A, Cristofanilli M, Lewis-Wambi J. PMID: 26897526; PMCID: PMC4761146.
    View in: PubMed Mentions: 52 Fields:
    Translation:HumansCells
  19. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death. Breast Cancer Res. 2015 Jan 15; 17:6. Choi HJ, Lui A, Ogony J, Jan R, Sims PJ, Lewis-Wambi J. PMID: 25588716; PMCID: PMC4336497.
    View in: PubMed Mentions: 28 Fields:
    Translation:HumansCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs